Health Competitors

Stocks . Taiwan . 
Stock . Health Life Co
1781 Stock  TWD 12.40  0.35  2.90%   
Health Life competes with A SPINE, 4170, TaiwanJ Pharmaceuticals, Pharmigene, and EPS Bio; as well as few others. Analyzing Health Life competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Health Life to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Health Life Correlation with its peers.

Health Life vs Sofiva Genomics Correlation

Significant diversification

The correlation between Health Life Co and 6615 is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Health Life Co and 6615 in the same portfolio, assuming nothing else is changed.
Hype
Prediction
LowEstimatedHigh
10.8412.4013.96
Details
Intrinsic
Valuation
LowRealHigh
10.4812.0413.60
Details
Naive
Forecast
LowNextHigh
10.8912.4514.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
10.4711.5812.70
Details

Health Life Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Health Life and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Health and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Health Life does not affect the price movement of the other competitor.

High positive correlations

3373
+ 0.8
4183
4183
+ 0.69
6549
6615
+ 0.66
6549
6615
+ 0.64
4183
3373
+ 0.54
6549
6549
+ 0.53
6758
  

High negative correlations

4183
- 0.3
4170
6615
- 0.28
4170
4183
- 0.26
7607
6615
- 0.25
7607
6797
- 0.25
6549
6549
- 0.22
4170

Risk-Adjusted Indicators

There is a big difference between Health Stock performing well and Health Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Health Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
6758  0.64 (0.05) 0.00  0.37  0.00 
 0.00 
 1.62 
(3.97)
 8.78 
4170  2.24  0.03  0.00  0.03  0.00 
 0.00 
 4.44 
(3.81)
 19.83 
6549  1.28  0.28  0.13 (1.76) 1.09 
(1.83)
 4.07 
(2.74)
 7.70 
4115  1.30  0.04 (0.01) 0.19  1.46 
(2.30)
 3.95 
(3.57)
 8.68 
7607  1.77 (0.18) 0.00  4.72  0.00 
 0.00 
 4.63 
(4.65)
 13.34 
7595  1.50 (0.09) 0.00 (0.93) 0.00 
 0.00 
 4.12 
(3.82)
 7.95 
4183  1.01 (0.20) 0.00 (0.46) 0.00 
 0.00 
 2.64 
(2.35)
 8.43 
6797  2.23  0.03 (0.01)(0.71) 3.35 
(2.50)
 4.65 
(7.10)
 22.74 
3373  0.64 (0.22) 0.00 (4.79) 0.00 
 0.00 
 0.84 
(1.64)
 3.98 
6615  0.90 (0.11) 0.00 (0.57) 0.00 
 0.00 
 2.28 
(2.54)
 7.08 

Health Life Competitive Analysis

The better you understand Health Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Health Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Health Life's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
1781 6758 4170 6549 4115 7607 7595 4183 6797 3373
 2.90 
 12.40 
Health
 0.52 
 38.50 
6758
 0.72 
 13.90 
4170
 3.19 
 8.42 
TaiwanJ
 3.95 
 8.42 
Sunder
 3.66 
 18.45 
7607
 5.13 
 10.05 
Pharmigene
 1.23 
 16.00 
EPS
 1.31 
 15.10 
Taiwan
 0.59 
 17.10 
Radiant
Market Volatility
(90 Days Market Risk)
Not too volatile
Very steady
Somewhat reliable
Somewhat reliable
Somewhat reliable
Not too volatile
Not too volatile
Very steady
Somewhat reliable
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Good
Weak
Weakest
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Fair
Low
High
Average
Unknown
Unknown
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Sell
Current Ratio
N/A
N/A
4.47
14.77
N/A
N/A
14.16
2.88
2.62
N/A
Net Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.24 B
Profit Margin
N/A
N/A
-14.7
-237.97
N/A
N/A
-11.06
9.33
33.89
0.071
EBITDA
N/A
N/A
(55.28 M)
10.42 M
N/A
N/A
(8.73 M)
46.92 M
809.69 M
177.56 M
Operating Margin
N/A
N/A
-32.96
-16.9
N/A
N/A
-13.68
7.56
40.21
0.0038
Current Valuation
N/A
N/A
674.16 M
641.12 M
N/A
N/A
717.33 M
345.41 M
945.75 M
987.21 M
Price To Book
N/A
N/A
2.24
4.23
N/A
N/A
2.49
1.36
1.34
1.15
Beta
N/A
N/A
0.41
0.27
N/A
N/A
N/A
1.3
N/A
-0.085
Number Of Employees
7
N/A
10
16
N/A
N/A
N/A
121
N/A
13
Shares Outstanding
N/A
13.47 M
42.14 M
69.2 M
N/A
N/A
43.47 M
23.8 M
23.17 M
43.29 M
Cash Flow From Operations
N/A
N/A
(85.28 M)
10.53 M
N/A
N/A
(12.78 M)
37.37 M
789.25 M
(135.16 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0584
Total Debt
N/A
N/A
N/A
477 K
N/A
N/A
21.63 M
141.01 M
553.23 M
N/A
Return On Equity
N/A
N/A
-8.33
-58.57
N/A
N/A
-4.15
14.88
50.59
0.0417
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
28.2
1.2
1.2
N/A
Return On Asset
N/A
N/A
-8.59
-2.5
N/A
N/A
-2.79
4.42
19.95
0.0012
Book Value Per Share
N/A
N/A
7.96
2.6
N/A
N/A
9.42
12.43
44.83
23.86
Total Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.24 B
Last Dividend Paid
N/A
2.5
N/A
N/A
N/A
N/A
N/A
0.7
6.0
1.5
Debt To Equity
N/A
N/A
N/A
0.2
N/A
N/A
0.052
47.6
0.35
N/A
Market Capitalization
538.08 M
693.76 M
752.21 M
741.16 M
N/A
N/A
1.02 B
402.22 M
1.39 B
1.09 B
Price To Earning
N/A
N/A
N/A
N/A
N/A
N/A
N/A
9.74
1.98
N/A
Price To Sales
N/A
N/A
3.65
12.01
N/A
N/A
10.06
0.9
0.74
1.9
Net Income
N/A
N/A
(30.32 M)
(146.88 M)
N/A
N/A
(11.21 M)
41.47 M
636.96 M
112.47 M
Earnings Per Share
N/A
N/A
-0.72
-2.14
N/A
N/A
-0.33
1.74
30.37
1.0
Shares Owned By Insiders
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
28.78
Revenue
N/A
N/A
206.33 M
61.72 M
N/A
N/A
101.35 M
444.68 M
1.88 B
985.04 M
Cash And Equivalents
N/A
N/A
80 M
100.1 M
N/A
N/A
297.48 M
202.58 M
1.37 B
N/A
Cash Per Share
N/A
N/A
1.9
1.45
N/A
N/A
6.84
8.51
45.56
N/A
Gross Profit
N/A
N/A
159 M
N/A
N/A
N/A
44.29 M
95.71 M
1.07 B
307.55 M
Day Typical Price
12.3
38.48
13.78
8.54
8.42
18.68
10.03
16.03
15.02
17.15
Accumulation Distribution
731.98
0.0013
204.01
64964.67
N/A
1758.55
0.005
167.7
0.0552
2646.08
Market Facilitation Index
0.0
0.05
0.0
0.0
N/A
0.0
0.05
0.0
0.85
0.0
Daily Balance Of Power
1.166667
4.0
0.2857
0.1985
9.2 T
(1.00)
9.8
(2.00)
(0.24)
0.2857
Period Momentum Indicator
0.35
0.2
0.1
0.26
0.32
(0.70)
0.49
(0.20)
(0.20)
0.1
Rate Of Daily Change
1.03
1.01
1.01
1.03
1.04
0.96
1.05
0.99
0.99
1.01
Day Median Price
12.25
38.48
13.73
8.6
8.42
18.8
10.03
16.05
14.98
17.18
Price Action Indicator
0.33
0.13
0.22
(0.04)
0.16
(0.70)
0.27
(0.15)
0.025
(0.03)
Relative Strength Index
63.54
N/A
49.15
N/A
N/A
N/A
N/A
36.0
47.23
34.33
Coefficient Of Variation
(137,942)
(2,371)
(23,802)
653.81
2786.07
(1,492)
(3,005)
(889.54)
8593.41
(409.63)
Mean Deviation
0.7605
0.6434
2.24
1.28
1.3
1.77
1.5
1.01
2.23
0.6358
Jensen Alpha
(0.03)
(0.05)
0.0274
0.276
0.0358
(0.18)
(0.09)
(0.20)
0.034
(0.22)
Total Risk Alpha
(0.16)
(0.19)
(0.32)
0.0913
(0.12)
(0.44)
(0.28)
(0.32)
(0.31)
(0.29)
Sortino Ratio
N/A
N/A
N/A
0.1286
(0.01)
N/A
N/A
N/A
(0.01)
N/A
Downside Variance
N/A
N/A
N/A
2.28
4.75
N/A
N/A
N/A
17.18
N/A
Standard Deviation
1.53
1.32
3.05
1.8
1.89
2.6
2.08
1.49
3.52
0.832
Kurtosis
26.04
7.22
2.56
0.9515
0.5679
2.54
0.1314
1.95
3.23
1.03
Potential Upside
0.9132
1.62
4.44
4.07
3.95
4.63
4.12
2.64
4.65
0.838
Treynor Ratio
(0.05)
0.3681
0.0322
(1.76)
0.1862
4.72
(0.93)
(0.46)
(0.71)
(4.79)
Maximum Drawdown
10.6
8.78
19.83
7.7
8.68
13.34
7.95
8.43
22.74
3.98
Variance
2.33
1.74
9.28
3.24
3.57
6.75
4.31
2.22
12.39
0.6923
Market Risk Adjusted Performance
(0.04)
0.3781
0.0422
(1.75)
0.1962
4.73
(0.92)
(0.45)
(0.70)
(4.78)
Risk Adjusted Performance
0.0047
(0.03)
0.0045
0.1182
0.0325
(0.04)
(0.02)
(0.08)
0.0165
(0.18)
Skewness
4.1
(0.84)
(0.19)
0.6626
0.1994
0.7858
0.3551
0.5686
0.2005
0.1092
Semi Deviation
N/A
N/A
N/A
1.09
1.46
N/A
N/A
N/A
3.35
N/A
Information Ratio
(0.05)
(0.10)
(0.03)
0.108
(0.01)
(0.1)
(0.07)
(0.17)
(0.01)
(0.34)
Value At Risk
(1.33)
(3.97)
(3.81)
(2.74)
(3.57)
(4.65)
(3.82)
(2.35)
(7.10)
(1.64)
Expected Short fall
N/A
N/A
N/A
(1.83)
(2.30)
N/A
N/A
N/A
(2.50)
N/A
Downside Deviation
N/A
N/A
N/A
1.51
2.18
N/A
N/A
N/A
4.15
N/A
Semi Variance
N/A
N/A
N/A
1.18
2.12
N/A
N/A
N/A
11.25
N/A

Health Life Competition Performance Charts

Five steps to successful analysis of Health Life Competition

Health Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Health Life in relation to its competition. Health Life's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Health Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Health Life's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Health Life, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Health Life position

In addition to having Health Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Value Funds Thematic Idea Now

Large Value Funds
Large Value Funds Theme
Funds or Etfs that invest in the undervalued stocks of large-sized companies. The Large Value Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Value Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Health Stock Analysis

When running Health Life's price analysis, check to measure Health Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Life is operating at the current time. Most of Health Life's value examination focuses on studying past and present price action to predict the probability of Health Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Life's price. Additionally, you may evaluate how the addition of Health Life to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY